Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2015
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortalityMargaret L MacMillan, Marie Robin, Andrew C Harris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial ResultsJoseph Pidala, Kelly Walton, Hany Elmariah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2023
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict MortalityShernan G Holtan, Constanza Savid-Frontera, Kelly Walton, et al.
Transplantation and Cellular Therapy|June 13, 2023
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate MofetilNajla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Blood|November 19, 2019
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trialJoseph Pidala, Mehdi Hamadani, Peter Dawson, et al.
Blood|July 24, 2024
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial resultsJoseph Pidala, Shernan G Holtan, Kelly Walton, et al.
Blood Cancer Journal|May 19, 2021
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood groupNajla El Jurdi, Heba Elhusseini, Joan Beckman, et al.
Transplantation and Cellular Therapy|March 4, 2023
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple MyelomaRajshekhar Chakraborty, Jean Yi, Lisa Rybicki, et al.
Blood Advances|April 3, 2020
Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factorShernan G Holtan, Andrea L Hoeschen, Qing Cao, et al.
Blood|March 30, 2016
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cellsAmina Kariminia, Shernan G Holtan, Sabine Ivison, et al.
Pageof 15